|
1
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2021. CA Cancer J Clin. 71:7–33. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Roulot A, Héquet D, Guinebretière JM,
Vincent-Salomon A, Lerebours F, Dubot C and Rouzier R: Tumoral
heterogeneity of breast cancer. Ann Biol Clin (Paris). 74:653–660.
2016.
|
|
3
|
Yeo SK and Guan JL: Breast cancer:
Multiple Subtypes within a Tumor? Trends Cancer. 3:753–760. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gao JJ and Swain SM: Luminal A breast
cancer and molecular assays: A review. Oncologist. 23:556–565.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ades F, Zardavas D, Bozovic-Spasojevic I,
Pugliano L, Fumagalli D, de Azambuja E, Viale G, Sotiriou C and
Piccart M: Luminal B breast cancer: Molecular characterization,
clinical management, and future perspectives. J Clin Oncol.
32:2794–2803. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Prat A, Pineda E, Adamo B, Galván P,
Fernández A, Gaba L, Díez M, Viladot M, Arance A and Muñoz M:
Clinical implications of the intrinsic molecular subtypes of breast
cancer. Breast. 24(Suppl 2): S26–S35. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yin L, Duan JJ, Bian XW and Yu SC:
Triple-negative breast cancer molecular subtyping and treatment
progress. Breast Cancer Res. 22:612020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hao S, Ha L, Cheng G, Wan Y, Xia Y,
Sosnoski DM, Mastro AM and Zheng SY: A Spontaneous 3D
Bone-On-a-Chip for bone metastasis study of breast cancer cells.
Small. 14:e17027872018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Watase C, Shiino S, Shimoi T, Noguchi E,
Kaneda T, Yamamoto Y, Yonemori K, Takayama S and Suto A: Breast
cancer brain metastasis-overview of disease state, treatment
options and future perspectives. Cancers (Basel). 13:10782021.
View Article : Google Scholar
|
|
10
|
Maughan KL, Lutterbie MA and Ham PS:
Treatment of breast cancer. Am Fam Physician. 81:1339–1346.
2010.PubMed/NCBI
|
|
11
|
Elsayed M, Alhussini M, Basha A and Awad
AT: Analysis of loco-regional and distant recurrences in breast
cancer after conservative surgery. World J Surg Oncol. 14:1442016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Salata C, deAlmeida CE, Ferreira-Machado
SC, Barroso RC, Nogueira LP, Mantuano A, Pickler A, Mota CL and de
Andrade CBV: Preliminary pre-clinical studies on the side effects
of breast cancer treatment. Int J Radiat Biol. 97:877–887. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Taylor CW and Kirby AM: Cardiac
Side-effects from breast cancer radiotherapy. Clin Oncol (R Coll
Radiol). 27:621–629. 2015. View Article : Google Scholar
|
|
14
|
Tsuno A, Miyoshi K, Tsujii R, Miyakawa T
and Mizuta K: RRS1, a conserved essential gene, encodes a novel
regulatory protein required for ribosome biogenesis in
Saccharomyces cerevisiae. Mol Cell Biol. 20:2066–2074. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hua Y, Song J, Peng C, Wang R, Ma Z, Zhang
J, Zhang Z, Li N and Hou L: Advances in the relationship between
regulator of ribosome Synthesis 1 (RRS1) and diseases. Front Cell
Dev Biol. 9:6209252021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Granneman S and Baserga SJ: Ribosome
biogenesis: Of knobs and RNA processing. Exp Cell Res. 296:43–50.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Baßler J and Hurt E: Eukaryotic ribosome
assembly. Annu Rev Biochem. 88:281–306. 2019. View Article : Google Scholar
|
|
18
|
Zhang J, Harnpicharnchai P, Jakovljevic J,
Tang L, Guo Y, Oeffinger M, Rout MP, Hiley SL, Hughes T and
Woolford JL Jr: Assembly factors Rpf2 and Rrs1 recruit 5S rRNA and
ribosomal proteins rpL5 and rpL11 into nascent ribosomes. Genes
Dev. 21:2580–2592. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gambe AE, Matsunaga S, Takata H,
Ono-Maniwa R, Baba A, Uchiyama S and Fukui K: A nucleolar protein
RRS1 contributes to chromosome congression. FEBS Lett.
583:1951–1956. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Horigome C, Okada T, Shimazu K, Gasser SM
and Mizuta K: Ribosome biogenesis factors bind a nuclear envelope
SUN domain protein to cluster yeast telomeres. EMBO J.
30:3799–3811. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Miyoshi K, Tsujii R, Yoshida H, Maki Y,
Wada A, Matsui Y, Toh-E A and Mizuta K: Normal assembly of 60S
ribosomal subunits is required for the signaling in response to a
secretory defect in Saccharomyces cerevisiae. J Biol Chem.
277:18334–18339. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Carnemolla A, Fossale E, Agostoni E,
Michelazzi S, Calligaris R, De Maso L, Del Sal G, MacDonald ME and
Persichetti F: Rrs1 is involved in endoplasmic reticulum stress
response in Huntington disease. J Biol Chem. 284:18167–18173. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang Y, Sun B, Zhao L, Liu Z, Xu Z, Tian
Y and Hao C: Up-regulation of miRNA-148a inhibits proliferation,
invasion, and migration while promoting apoptosis of cervical
cancer cells by down-regulating RRS1. Biosci Rep.
39:BSR201818152019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang J, Li Z, Zuo C, Xie Q, Li H, Jia J,
Zhen Z, Qi R, Li Z, Liu D and Sun B: Knockdown of RRS1 by
lentiviral-mediated RNAi promotes apoptosis and suppresses
proliferation of human hepatocellular carcinoma cells. Oncol Rep.
38:2166–2172. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hua YN, Song JL, Ma ZL, Wu L, Zhang Z,
Zhang L, Li N, Cong SB and Hou L: Effect of RRS1 gene knockdown on
BT549 cell line proliferation and apoptosis in breast cancer.
Neoplasma. 66:28–32. 2019. View Article : Google Scholar
|
|
26
|
Song J, Ma Z, Hua Y, Xu J, Li N, Ju C and
Hou L: Functional role of RRS1 in breast cancer cell proliferation.
J Cell Mol Med. 22:6304–6313. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen F, Jin Y, Feng L, Zhang J, Tai J, Shi
J, Yu Y, Lu J, Wang S, Li X, et al: RRS1 gene expression involved
in the progression of papillary thyroid carcinoma. Cancer Cell Int.
18:202018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
XL Wu, Yang ZW, He L, Dong PD, Hou MX,
Meng XK, Zhao HP, Wang ZY, Wang F, Baoluri, et al: RRS1 silencing
suppresses colorectal cancer cell proliferation and tumorigenesis
by inhibiting G2/M progression and angiogenesis. Oncotarget.
8:82968–82980. 2017. View Article : Google Scholar
|
|
29
|
Ma Y, Yan F, Wei W, Deng J, Li L, Liu L
and Sun J: MicroRNA-598 inhibits the growth and maintenance of
gastric cancer stem-like cells by down-regulating RRS1. Cell Cycle.
18:2757–2769. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cao P, Yang A, Li P, Xia X, Han Y, Zhou G,
Wang R, Yang F, Li Y, Zhang Y, et al: Genomic gain of RRS1 promotes
hepatocellular carcinoma through reducing the RPL11-MDM2-p53
signaling. Sci Adv. 7:eabf43042021. View Article : Google Scholar :
|
|
31
|
Calviño FR, Kharde S, Ori A, Hendricks A,
Wild K, Kressler D, Bange G, Hurt E, Beck M and Sinning I:
Symportin 1 chaperones 5S RNP assembly during ribosome biogenesis
by occupying an essential rRNA-binding site. Nat Commun.
6:65102015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang Y, Wolf GW, Bhat K, Jin A, Allio T,
Burkhart WA and Xiong Y: Ribosomal protein L11 negatively regulates
oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress
checkpoint pathway. Mol Cell Biol. 23:8902–8912. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Haupt Y, Maya R, Kazaz A and Oren M: Mdm2
promotes the rapid degradation of p53. Nature. 387:296–299. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Momand J, Zambetti GP, Olson DC, George D
and Levine AJ: The mdm-2 oncogene product forms a complex with the
p53 protein and inhibits p53-mediated transactivation. Cell.
69:1237–1245. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bursać S, Brdovčak MC, Pfannkuchen M,
Orsolić I, Golomb L, Zhu Y, Katz C, Daftuar L, Grabušić K, Vukelić
I, et al: Mutual protection of ribosomal proteins L5 and L11 from
degradation is essential for p53 activation upon ribosomal
biogenesis stress. Proc Natl Acad Sci USA. 109:20467–20472. 2012.
View Article : Google Scholar
|
|
36
|
Horn HF and Vousden KH: Cooperation
between the ribosomal proteins L5 and L11 in the p53 pathway.
Oncogene. 27:5774–5784. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang HT, Chen TY, Weng CW, Yang CH and
Tang MS: Acrolein preferentially damages nucleolus eliciting
ribosomal stress and apoptosis in human cancer cells. Oncotarget.
7:80450–80464. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dai MS, Arnold H, Sun XX, Sears R and Lu
H: Inhibition of c-Myc activity by ribosomal protein L11. EMBO J.
26:3332–3345. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
van Riggelen J, Yetil A and Felsher DW:
MYC as a regulator of ribosome biogenesis and protein synthesis.
Nat Rev Cancer. 10:301–309. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Dai MS, Sears R and Lu H: Feedback
regulation of c-Myc by ribosomal protein L11. Cell Cycle.
6:2735–2741. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang X, Ren Y, Wang Z, Xiong X, Han S, Pan
W, Chen H, Zhou L, Zhou C, Yuan Q and Yang M: Down-regulation of 5S
rRNA by miR-150 and miR-383 enhances c-Myc-rpL11 interaction and
inhibits proliferation of esophageal squamous carcinoma cells. FEBS
Lett. 589:3989–3997. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gao X, Liu X, Lu Y, Wang Y, Cao W, Liu X,
Hu H and Wang H: PIM1 is responsible for IL-6-induced breast cancer
cell EMT and stemness via c-myc activation. Breast Cancer.
26:663–671. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yang J, Wu SP, Wang WJ, Jin ZR, Miao XB,
Wu Y, Gou DM, Liu QZ and Yao KT: A novel miR-200c/c-myc negative
regulatory feedback loop is essential to the EMT process, CSC
biology and drug sensitivity in nasopharyngeal cancer. Exp Cell
Res. 391:1118172020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tao L, Shu-Ling W, Jing-Bo H, Ying Z, Rong
H, Xiang-Qun L, Wen-Jie C and Lin-Fu Z: MiR-451a attenuates
doxorubicin resistance in lung cancer via suppressing
epithelialmesenchymal transition (EMT) through targeting c-Myc.
Biomed Pharmacother. 125:1099622020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Liu N, Wang Z, Liu D and Xie P:
HOXC13-AS-miR-122-5p-S ATB1-C-Myc feedback loop promotes migration,
invasion and EMT process in glioma. Onco Targets Ther.
12:7165–7173. 2019. View Article : Google Scholar :
|
|
46
|
Lin X, Sun R, Zhao X, Zhu D, Zhao X, Gu Q,
Dong X, Zhang D, Zhang Y, Li Y and Sun B: C-myc overexpression
drives melanoma metastasis by promoting vasculogenic mimicry via
c-myc/snail/Bax signaling. J Mol Med (Berl). 95:53–67. 2017.
View Article : Google Scholar
|
|
47
|
Wang K, Zheng J, Yu J, Wu Y, Guo J, Xu Z
and Sun X: Knockdown of MMP-1 inhibits the progression of
colorectal cancer by suppressing the PI3K/Akt/c-myc signaling
pathway and EMT. Oncol Rep. 43:1103–1112. 2020.PubMed/NCBI
|
|
48
|
Nieto MA, Huang RY, Jackson RA and Thiery
JP: EMT: 2016. Cell. 166:21–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
50
|
Madru C, Lebaron S, Blaud M, Delbos L,
Pipoli J, Pasmant E, Réty S and Leulliot N: Chaperoning 5S RNA
assembly. Genes Dev. 29:1432–1446. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Smith AP, Verrecchia A, Fagà G, Doni M,
Perna D, Martinato F, Guccione E and Amati B: A positive role for
Myc in TGFbeta-induced Snail transcription and
epithelial-to-mesenchymal transition. Oncogene. 28:422–430. 2009.
View Article : Google Scholar
|
|
52
|
Azamjah N, Soltan-Zadeh Y and Zayeri F:
Global trend of breast cancer mortality rate: A 25-year study.
Asian Pac J Cancer Prev. 20:2015–2020. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Henson KE, McGale P, Darby SC, Parkin M,
Wang Y and Taylor CW: Cardiac mortality after radiotherapy,
chemotherapy and endocrine therapy for breast cancer: Cohort study
of 2 million women from 57 cancer registries in 22 countries. Int J
Cancer. 147:1437–1449. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Penzo M, Montanaro L, Treré D and
Derenzini M: The ribosome biogenesis-cancer connection. Cells.
8:552019. View Article : Google Scholar
|
|
55
|
Nait Slimane S, Marcel V, Fenouil T, Catez
F, Saurin JC, Bouvet P, Diaz JJ and Mertani HC: Ribosome biogenesis
alterations in colorectal cancer. Cells. 9:23612020. View Article : Google Scholar :
|
|
56
|
Baßler J, Paternoga H, Holdermann I, Thoms
M, Granneman S, Barrio-Garcia C, Nyarko A, Lee W, Stier G, Clark
SA, et al: A network of assembly factors is involved in remodeling
rRNA elements during preribosome maturation. J Cell Biol.
207:481–498. 2014. View Article : Google Scholar
|
|
57
|
Ulbrich C, Diepholz M, Bassler J, Kressler
D, Pertschy B, Galani K, Böttcher B and Hurt E: Mechanochemical
removal of ribosome biogenesis factors from nascent 60S ribosomal
subunits. Cell. 138:911–922. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Micic J, Li Y, Wu S, Wilson D, Tutuncuoglu
B, Gao N and Woolford JL Jr: Coupling of 5S RNP rotation with
maturation of functional centers during large ribosomal subunit
assembly. Nat Commun. 11:37512020. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Davis AC, Wims M, Spotts GD, Hann SR and
Bradley A: A null c-myc mutation causes lethality before 10.5 days
of gestation in homozygotes and reduced fertility in heterozygous
female mice. Genes Dev. 7:671–682. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Destefanis F, Manara V and Bellosta P: Myc
as a regulator of ribosome biogenesis and cell competition: A link
to cancer. Int J Mol Sci. 21:40372020. View Article : Google Scholar :
|
|
61
|
Wu H, Yang TY, Li Y, Ye WL, Liu F, He XS,
Wang JR, Gan WJ, Li XM, Zhang S, et al: Tumor necrosis factor
receptor-associated Factor 6 promotes hepatocarcinogenesis by
interacting with histone deacetylase 3 to enhance c-Myc Gene
expression and protein stability. Hepatology. 71:148–163. 2020.
View Article : Google Scholar
|
|
62
|
Liao JM, Zhou X, Gatignol A and Lu H:
Ribosomal proteins L5 and L11 co-operatively inactivate c-Myc via
RNA-induced silencing complex. Oncogene. 33:4916–4923. 2014.
View Article : Google Scholar
|
|
63
|
Challagundla KB, Sun XX, Zhang X, DeVine
T, Zhang Q, Sears RC and Dai MS: Ribosomal protein L11 recruits
miR-24/miRISC to repress c-Myc expression in response to ribosomal
stress. Mol Cell Biol. 31:4007–4021. 2011. View Article : Google Scholar : PubMed/NCBI
|
